| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/26/2005 | EP1499352A1 Recombinant anti-interleukin-9 antibodies |
| 01/26/2005 | EP1499345A2 Protein a compositions and methods of use |
| 01/26/2005 | EP1499336A2 Protease inhibitors |
| 01/26/2005 | EP1499335A2 Chimeric hybrid analgesics |
| 01/26/2005 | EP1499329A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 01/26/2005 | EP1499327A2 Beta -amyloid peptide-binding proteins and polynucleotides encoding the same |
| 01/26/2005 | EP1499322A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 01/26/2005 | EP1499321A2 Methods for increasing the therapeutic response to electroconvulsive therapy ("ect") |
| 01/26/2005 | EP1499320A1 Novel compounds |
| 01/26/2005 | EP1499316A1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 01/26/2005 | EP1499315A1 Combination of cyclooxygenase-2 inhibitors and thalidomide for the treatment of neoplasia |
| 01/26/2005 | EP1499314A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders |
| 01/26/2005 | EP1499313A2 Heterocyclic derivatives as opioid receptor modulators |
| 01/26/2005 | EP1499309A1 Prevention and treatment of functional somatic disorders, including stress-related disorders |
| 01/26/2005 | EP1499306A2 Bicyclic amides |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP1499291A1 Methods and dosage forms for controlled delivery of oxycodone |
| 01/26/2005 | EP1499204A2 Physiologically compatible, phospholipid-containing, stable and hard matrix |
| 01/26/2005 | EP1499190A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b |
| 01/26/2005 | EP1499186A1 Use of heme oxygenase-1 and products of heme degradation |
| 01/26/2005 | EP1441704B1 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 01/26/2005 | EP1406871A4 Process for the production of n- 3-(3-cyanopyrazolo 1,5-a] pyrimidin-7-yl)phenyl]-n-ethylacetamide (zaleplon) |
| 01/26/2005 | EP1406610B1 Use of substituted gamma-lactone compounds as medicaments |
| 01/26/2005 | EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I |
| 01/26/2005 | EP1307463B1 Pyrrolo 2,1-b]-[1,3]benzothiazepines and their use for the preparation of medicaments with antipsychotic activity |
| 01/26/2005 | EP1301514B1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP1283047A4 Method for producing a bioactive substance from blood serum |
| 01/26/2005 | EP1278749B1 USE OF 5-THIO-, SULFINYL- AND SULFONYLPYRAZOLO 3,4-b]-PYRIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 01/26/2005 | EP1203233B1 Method for identifying modulating compounds of neurotransmitters |
| 01/26/2005 | EP1185524B1 3-heteroarylalkyl substituted gaba analogs |
| 01/26/2005 | EP1117409B1 Benzenesulfonyl(thio)ureas in combination with beta-blockers for the treatment of dysfunctions of the autonomous nervous system |
| 01/26/2005 | EP1084109B1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | EP0944592B1 Vitamin d3 derivatives |
| 01/26/2005 | EP0920423B1 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists |
| 01/26/2005 | EP0886651B1 Persephin and related growth factors |
| 01/26/2005 | EP0866691B2 Sublingual and buccal administration of selegiline |
| 01/26/2005 | CN1571796A Melanocortin receptor ligands |
| 01/26/2005 | CN1571794A Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 01/26/2005 | CN1571793A Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571787A Quinuclidine derivatives processes for preparing them and their uses as M2 and/or M3 muscarinic receptor inhibitors |
| 01/26/2005 | CN1571786A Alkyl ether derivatives or salts thereof |
| 01/26/2005 | CN1571784A Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 01/26/2005 | CN1571783A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1571770A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/26/2005 | CN1571670A Treating sexual desire disorders with flibanserin |
| 01/26/2005 | CN1571669A Novel combination |
| 01/26/2005 | CN1571664A Percutaneous absorption preparations |
| 01/26/2005 | CN1571662A Highly compressible ethylcellulose for tableting |
| 01/26/2005 | CN1571660A Solid pharmaceutical agent formulation for a piperazine urea derivative |
| 01/26/2005 | CN1569899A Recombinant nerve putrescence virus protein vaccine and its coding sequence and uses |
| 01/26/2005 | CN1569883A Pineapple anhydride compound and its use |
| 01/26/2005 | CN1569838A Meptazinol ortho-propionyloxy-cis-benzyl acrylate and its salts and their production method |
| 01/26/2005 | CN1569777A Chiral source and pharmaceutical salt or complex of organic alkali drug |
| 01/26/2005 | CN1569222A Preparation method of NGF oral capsule |
| 01/26/2005 | CN1569221A VEGF plasmid-liposome complex and its usage |
| 01/26/2005 | CN1569216A Nanometer natural biological protein bee product and its preparation |
| 01/26/2005 | CN1569194A Chinese medicine for treating side reaction caused by insanity resisting medicine and its preparation method |
| 01/26/2005 | CN1569179A Chinese medicine for giving up drugs |
| 01/26/2005 | CN1569148A Medicament for preventing and treating rheumatic arthritis, rheumatoid disease and sciatic neuralgia and its preparation |
| 01/26/2005 | CN1569144A Medicine for treating cardiovascular and cerebrovascular disease and its preparing process |
| 01/26/2005 | CN1569142A Gastrodia tuber contained refractory headache treating formulation and its preparation technique and quality control method |
| 01/26/2005 | CN1569105A Natural herb made healthy product for resisting depression |
| 01/26/2005 | CN1569099A rheumatism treating Chinese medicinal paste |
| 01/26/2005 | CN1569087A Medicine for treating facial paralysis and its preparing method |
| 01/26/2005 | CN1569068A Preparation method of |
| 01/26/2005 | CN1569059A Insomnia treating drug |
| 01/26/2005 | CN1569050A Novel preparing technique of |
| 01/26/2005 | CN1569048A Novel method for preparing headache and vertigo treating medicine and its preparation |
| 01/26/2005 | CN1569030A Albumen removed extraction of calf blood for injection and its preparing process |
| 01/26/2005 | CN1569009A Dripping pills of acetylgastrodin for treating nervous headache and its preparing method |
| 01/26/2005 | CN1569004A Dripping pills of nefopam hydrochloride and its preparation method |
| 01/26/2005 | CN1569003A Coating agent for treating insomnia and its usage |
| 01/26/2005 | CN1569002A Dripping pills of flurazepam hydrochloride and its preparation method |
| 01/26/2005 | CN1569001A Dripping pills of doxepin hydrochloride and its preparation |
| 01/26/2005 | CN1568999A Stable freeze dried formulation of spheroidine for medical use |
| 01/26/2005 | CN1568987A Dripping pills of paroxetine hydrochloride and its preparation method |
| 01/26/2005 | CN1568985A Orally disintegrating tablet of Huperzine A and its preparation |
| 01/26/2005 | CN1568953A Method for preparing mental disease resistant medicine containing succinic acid |
| 01/26/2005 | CN1568948A Venlafaxine hydrochloride drop pills and preparation method thereof |
| 01/26/2005 | CN1568946A Maprotiline Hydrochloride drop pills and preparation method thereof |
| 01/26/2005 | CN1568944A Application of curcumin and its derivants to preparation of pharmaceutical for depression |
| 01/26/2005 | CN1186346C Thienopyrrolidinones |
| 01/26/2005 | CN1186334C Pharmaceutical application of benzofuranone derivatives |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/26/2005 | CN1186318C Novel benzenesulphonamide compound, its prepn. process and medicinal compsns. contg. them |
| 01/26/2005 | CN1186097C Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor |
| 01/26/2005 | CN1186094C Piracetam medicine composition with function of promoting thinking and memory and its preparation |
| 01/26/2005 | CN1186059C Chinese medicine for treating depression and anxiety |
| 01/26/2005 | CN1186035C Health food capsule with functions of sobering up, detoxicating, nourishing heart, tranquilizing and protecting liver and its production process |
| 01/26/2005 | CN1186029C Medicine for treating facial paralysis and its preparing process |
| 01/26/2005 | CN1186020C Acylbenzoxazine for enhancing synaptic response(s) |
| 01/25/2005 | US6846953 Treating central nervous system disorders such as pain, depression, anxiety, schizophrenia, Huntington's disease, Alzheimer's disease or amyotrophic lateral sclerosis |
| 01/25/2005 | US6846843 β-thioamino acids |
| 01/25/2005 | US6846832 Highly selective monoamine oxidase B inhibitors; treating Alzheimer's disease, Parkinson's disease, and senile dementia |
| 01/25/2005 | US6846830 Naphtalene derivatives and their pharmaceutical use |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |